Geol Choi - Seoulin Bioscience Managing Director

038070 Stock  KRW 7,340  230.00  3.23%   

Managing Director

Choi Geol Yong is Managing Director of Seoulin Bioscience Co., Ltd. Choi is also Head of Life Science Business Division of the Company. Previously, Choi was Head of the management support division of the Company. Choi holds a Master degree from Sejong University, Korea. since 2010.
Age 46
Tenure 15 years
Phone(82) 31 628 3007
Webwww.seoulin.co.kr

Seoulin Bioscience Management Efficiency

The company has return on total asset (ROA) of 0.0554 % which means that it generated a profit of $0.0554 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 10.8133 %, meaning that it generated $10.8133 on every $100 dollars invested by stockholders. Seoulin Bioscience's management efficiency ratios could be used to measure how well Seoulin Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.
Seoulin Bioscience CoLtd has accumulated 15.22 B in total debt with debt to equity ratio (D/E) of 0.01, which may suggest the company is not taking enough advantage from borrowing. Seoulin Bioscience CoLtd has a current ratio of 3.0, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Seoulin Bioscience until it has trouble settling it off, either with new capital or with free cash flow. So, Seoulin Bioscience's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Seoulin Bioscience CoLtd sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Seoulin to invest in growth at high rates of return. When we think about Seoulin Bioscience's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 2 records

MANAGING DIRECTOR Age

Jeonghyeok KimHyundai Heavy Industries
N/A
Seong ChoUNISEM Co
50
,Ltd., a bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea. The company was founded in 1984 and is headquartered in Seongnam, South Korea. SeouLin is traded on Korean Securities Dealers Automated Quotations in South Korea. Seoulin Bioscience CoLtd (038070) is traded on KOSDAQ in Korea and employs 91 people.

Management Performance

Seoulin Bioscience CoLtd Leadership Team

Elected by the shareholders, the Seoulin Bioscience's board of directors comprises two types of representatives: Seoulin Bioscience inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Seoulin. The board's role is to monitor Seoulin Bioscience's management team and ensure that shareholders' interests are well served. Seoulin Bioscience's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Seoulin Bioscience's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mi Kang, Assistant Managing Director
Jae Oh, Internal Auditor
NaeDong Kim, Director Director
Eul Hwang, Chief Executive Officer, Director
Wung Jeon, Non-Executive Independent Director
KulYong Choi, Director Director
Gi Choi, Managing Director
Geol Choi, Managing Director
Gil SiYang, Chief Director
IkYoung Kim, Advising Director
Jong Ahn, Managing Director

Seoulin Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Seoulin Bioscience a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Seoulin Bioscience

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Seoulin Bioscience position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seoulin Bioscience will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Seoulin Bioscience could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Seoulin Bioscience when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Seoulin Bioscience - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Seoulin Bioscience CoLtd to buy it.
The correlation of Seoulin Bioscience is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Seoulin Bioscience moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Seoulin Bioscience CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Seoulin Bioscience can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Seoulin Stock

Seoulin Bioscience financial ratios help investors to determine whether Seoulin Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seoulin with respect to the benefits of owning Seoulin Bioscience security.